title: Endothelial-mesenchymal transition in cerebral cavernous malformations and the unveiling of new potential therapeutic targets.
authors.affiliation: Department of Neurological Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.
authors.forename: Bradley A
authors.initials: BA
authors.lastname: Gross
authors.affiliation: Division of Neurological Surgery, Barrow Neurological Institute and St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA.
authors.forename: Felipe C
authors.initials: FC
authors.lastname: Albuquerque
mesh_terms: D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / Q000031:analogs & derivatives*; D000818:Animals; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D002538:Intracranial Arteriovenous Malformations / Q000188:drug therapy*; D014665:Vasodilator Agents / Q000627:therapeutic use*
chemical_list: D004791:Enzyme Inhibitors; D014665:Vasodilator Agents; D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine